1Fletcher AP, Alkjaersig N, Lewis M,et al. A pilot study of urokinase therapy in cerebral infarction. Stroke , 1976, 7:135-142.
2Abe T, Kazawa M, Naito I. Clinical effect of urokinase (6000 units? day) on cerebral infarction comparative study by means of multiple center double blind test.Blood Vessels, 1981,12 : 342-358.
3Genser N ,Lechleitner P,Maier J ,et al. Rebound increase of plasminogen activator inhibitor type Ⅰ after cessation of thromholytic treatment for acute myocardial infarction is independent of plasminogen activator used. Clin Chem, 1998,44:209-214.
4Grotta JC, Welch KMA, F, Fagan SC, et al. Clinical deterioration following improvement in the NINDS rTPA stroke trial . Stroke, 2001,32 : 661.
5Koennecke HC, Nohr R, Leistner S, et al. Intravenous tPA for ischemic stroke team performance over time , salty , and efficacy in single center , 2 year experience Stroke ,2001,32:10743.
